it was found later that trichomycin A, originally thought to be homogeneous, was in the form of complexmixtures of closely related compounds. This study is concerned with the isolation and characterization of new trichomycin A (1), the major constituent, from the complex mixtures using flash liquid chromatography (FLC) and HPLC. The biological properties of trichomycin A (1) are also briefly discussed. of DMF-5N-NaOH-acetone-water (6 : 2 : 27 : 3). The insoluble material was removed by filtration, and the filtrate was purified by column chromatography on alumina (acidic, Woelm) with acetone -water (9 : 1). The column was washed with 1/15m phosphate buffer (pH 8.0) followed with water. Trichomycin was eluted with a mixture of butanol-pyridine-water (4: 3 : 7). The eluate was concentrated in vacuo under 38°C in the dark, yielding an orange yellowish powder. It was further purified by column chromatography on silica gel 60 (Merck) with the lower phase of a mixture of chloroform-methanol -water (2 : 2 : 1). 1 was eluted from three times to seven times of the bed volume.
The eluate was concentrated in vacuo in the dark to yield a yellow powder. Further purification was achieved by FLC on silica gel (Fuji gel, 30~50^m) using the mentioned above solvent system, yielding Biological Activity The antifungal, anticandidal and antitrichomonal activities of 1 together with those of amphotericin B (Sigma) by the agar dilution method are shown in Table 1 . While trichomycin A (1) is more potent than amphothericin B, the well knownantifungal drug, against diverse strains and species of Candida 
